William Blair analyst Ross Sparenblek has maintained their bullish stance on SXI stock, giving a Buy rating on April 21.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Ross Sparenblek has given his Buy rating due to a combination of factors that highlight Standex International’s strategic positioning and financial performance. The company’s recent acquisitions, particularly Amran/Narayan and McStarlite, have significantly bolstered its revenue, offsetting challenges such as tariff disruptions. These acquisitions have not only provided accretive revenue but have also positioned Standex to better manage cyclical downturns in its end-markets.
Moreover, Standex’s focus on new product development and productivity initiatives has enhanced its earnings potential. The company’s third-quarter results exceeded expectations, with revenue and adjusted EPS surpassing consensus estimates. Looking ahead, Standex’s management anticipates improved revenue and operating margins, aligning with market expectations. This strategic foresight and operational resilience underpin Sparenblek’s confidence in Standex’s ability to emerge as a robust earnings compounder through economic cycles.
In another report released on April 21, D.A. Davidson also maintained a Buy rating on the stock with a $207.00 price target.